ARS Pharmaceuticals, Inc.
SPRY • NASDAQ • Stock Fundamentals
ARS Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard E. Lowenthal, with a market cap of $811.3M.
Market Cap$811.3M
Employees24.0
CEORichard E. Lowenthal
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
ARS Pharmaceuticals, Inc. FAQ
Common questions about ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. (SPRY) has a market capitalization of $811.3M and trades on NASDAQ.
ARS Pharmaceuticals, Inc. has approximately 24 employees.